Evidence map›Paper›PMID 38232167›Full record

ArticleScience advances2024

Doubling the life of Cu/ZnO methanol synthesis catalysts via use of Si as a structural promoter to inhibit sintering.

Nathan Barrow, Jonathan Bradley, Benjamin Corrie, Youxin Cui, Trung Dung Tran, Tugce Eralp Erden, Andrew Fish, Monica Garcia, Pauline Glen, Neetisha Mistry and 7 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nathan BarrowJohnson Matthey Technology Centre, Sonning Common, RG4 9NH, UK.ORCID 0000-0003-3462-2767
Jonathan BradleyJohnson Matthey Technology Centre, Sonning Common, RG4 9NH, UK.ORCID 0000-0003-0106-2062
Benjamin CorrieJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Youxin CuiJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.ORCID 0009-0005-3444-574X
Trung Dung TranJohnson Matthey Technology Centre, Sonning Common, RG4 9NH, UK.ORCID 0000-0001-9174-2680
Tugce Eralp ErdenJohnson Matthey Technology Centre, Sonning Common, RG4 9NH, UK.ORCID 0000-0002-0694-9538
Andrew FishJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.ORCID 0009-0004-2237-668X
Monica GarciaJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Pauline GlenJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.ORCID 0009-0008-0638-8559
Neetisha MistryJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.ORCID 0009-0009-6204-3210
Michael NicholsonJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Simone Roloff-StandringJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Daniel SheldonJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Thomas SmithJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Aron SummerJohnson Matthey Technology Centre, Sonning Common, RG4 9NH, UK.ORCID 0009-0001-6670-2350
Kaamila Un DinJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.
Norman MacleodJohnson Matthey, Catalyst Technologies, Billingham, TS23 1LB, UK.ORCID 0009-0006-9973-3758

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cu/ZnO/Al

Identifiers

PMID38232167
PMCPMC10793955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.